Pharmacyclics and Johnson & Johnson's Janssen Biotech Inc. unit partnered to co-develop and co-commercialize Pharmacyclics' PCI-32765

Pharmacyclics Inc.

U.S. / Small-Cap Biopharma (<$1 billion)

$998.9m on 12/16/2011 [market cap]

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Johnson & Johnson

U.S. / Large-Cap Biopharma (>=$50 billion)

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced